Main caricature of Dunston Almeida, who is speaking at HLTH and is EVP, Strategy and Business Development at eviCore healthcare Overlay caricature of Dunston Almeida, who is speaking at HLTH and is EVP, Strategy and Business Development at eviCore healthcare

Dunston Almeida

EVP, Strategy and Business Development

eviCore healthcare


Dunston is a Fortune 25 healthcare executive and entrepreneur with 20+ years of experience in tech and healthcare investing at leading global corporations. He was part of the executive team that grew eviCore from a few hundred million to $3.6 billion in just 4 years and its eventual sale to Express Scripts, the largest stand-alone PBM.

He is currently Executive Vice President of Strategy and Business Development at eviCore healthcare, the largest Medical Benefits Management (“MBM”) company covering 100 million lives across the US. Previously, he headed up Medco’s (Express Scripts) Emerging Markets strategies, including Brazil, India and China. Focus areas include AI and machine learning, post-acute care, medical and pharmacy data analytics, and precision oncology/genomics.

He has worked on transactions across the healthcare spectrum, including HCIT, CROs, home infusion, specialty pharma, Medicare/Medicaid and has completed over $30 billion of M&A in North America, Europe, Latin America and Asia with extensive experience across the entire capital structure.

He graduated from Cornell University with a degree in Electrical Engineering at the age of 20.